FY15 results on May 29, 2015
Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 29, 2015:1. To consider and approve the Company's Audited Financial Statements for the Year ended March 31, 2015.2. To Consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2015.... Glenmark Pharma gains on 'buy' rating
Glenmark Pharmaceuticals has gained 2.4 per cent. CLSA has given it a "buy" rating and a target price of Rs 1,060. It says the drugmaker is at the cusp of a revival wi... Disclosure of Voting results of EGM (Clause 35A)
Glenmark Pharmaceuticals Ltd has informed BSE regarding the details of Voting results at the Extra Ordinary General Meeting (EGM) of the Company held on May 13, 2015, under Clause 35A. Addendum to Notice of EGM on May 13, 2015
Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of Addendum to Notice dated April 17, 2015 of Extraordinary General Meeting scheduled to be held on May 13, 2015. Glenmark gets tentative USFDA nod for generic psoriasis cream
Glenmark Pharmaceuticals has received tentative approval from the US health regulator for generic Calcipotriene cream, used for the treatment of plaque psoriasis. It said in a statement that Glenmark Pharmaceuticals Inc, USA, a subsidiary of ... Glenmark rises on rating upgrade
Glenmark Pharmaceuticals shares gained over 1 per cent on Monday after Bank of America Merrill Lynchs upgrade.The investment bank upgraded the stock to "buy" from "underperform".At 9... Glenmark gets tentative USFDA nod for generic psoriasis cream
Glenmark Pharmaceuticals has received tentative approval from the US health regulator for generic Calcipotriene cream, used for the treatment of plaque psoriasis. It said in a statement t... Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene Cream, 0.005%
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated May 04, 2015, titled "Glenmark Pharmaceuticals receives tentative ANDA approval for Calcipotriene Cream, 0.005%". Glenmark Pharma gains on preferential issue plan to Temasek
The stock up 4% at Rs 898 on the National Stock Exchange. Glenmark shares up on Temasek investment plan
Shares in Glenmark Pharmaceuticals Ltd shot up 4 per cent in early trade on Monday. Singapore's state investment arm Temasek has said it will invest about $151 million in Glenmark. Assuming...